Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 3.450 Q1 | 117 | 551 | 994 | 23687 | 12239 | 988 | 10.91 | 42.99 | 42.42 | |
2 | Emerging Microbes and Infections | journal | 3.322 Q1 | 94 | 225 | 678 | 9428 | 9223 | 559 | 16.50 | 41.90 | 45.32 | |
3 | npj Vaccines | journal | 2.953 Q1 | 47 | 150 | 205 | 8502 | 1723 | 196 | 8.66 | 56.68 | 45.16 | |
4 | Protein and Cell | journal | 2.636 Q1 | 94 | 84 | 300 | 4240 | 2427 | 173 | 6.21 | 50.48 | 39.90 | |
5 | Acta Pharmaceutica Sinica B | journal | 2.200 Q1 | 99 | 268 | 378 | 25276 | 5268 | 358 | 14.27 | 94.31 | 41.40 | |
6 | Theranostics | journal | 2.061 Q1 | 158 | 557 | 1796 | 39471 | 20798 | 1786 | 10.94 | 70.86 | 40.46 | |
7 | Molecular Therapy - Nucleic Acids | journal | 1.852 Q1 | 95 | 338 | 838 | 20225 | 7985 | 834 | 9.74 | 59.84 | 41.28 | |
8 | Expert Review of Vaccines | journal | 1.689 Q1 | 105 | 137 | 298 | 12252 | 1688 | 279 | 5.13 | 89.43 | 42.95 | |
9 | Journal of Nanobiotechnology | journal | 1.557 Q1 | 109 | 438 | 391 | 28040 | 4765 | 391 | 8.76 | 64.02 | 40.19 | |
10 | Bioengineering and Translational Medicine | journal | 1.470 Q1 | 28 | 57 | 33 | 3764 | 236 | 25 | 7.15 | 66.04 | 37.13 | |
11 | Human Genomics | journal | 1.456 Q1 | 68 | 71 | 160 | 3876 | 915 | 155 | 6.16 | 54.59 | 42.80 | |
12 | PLoS Neglected Tropical Diseases | journal | 1.450 Q1 | 163 | 997 | 2546 | 53054 | 12506 | 2492 | 4.72 | 53.21 | 42.37 | |
13 | Therapeutic Advances in Neurological Disorders | journal | 1.447 Q1 | 68 | 101 | 224 | 4769 | 1467 | 213 | 6.18 | 47.22 | 37.70 | |
14 | Particle and Fibre Toxicology | journal | 1.437 Q1 | 119 | 48 | 154 | 3323 | 1310 | 153 | 8.01 | 69.23 | 44.74 | |
15 | International Journal of Neuropsychopharmacology | journal | 1.417 Q1 | 125 | 114 | 248 | 7218 | 1419 | 245 | 5.39 | 63.32 | 38.88 | |
16 | Journal of Pharmaceutical Analysis | journal | 1.390 Q1 | 51 | 85 | 174 | 4496 | 1954 | 171 | 14.51 | 52.89 | 42.42 | |
17 | npj Systems Biology and Applications | journal | 1.390 Q1 | 35 | 45 | 111 | 3081 | 566 | 110 | 4.09 | 68.47 | 35.92 | |
18 | CNS Neuroscience and Therapeutics | journal | 1.364 Q1 | 91 | 148 | 405 | 8013 | 2398 | 355 | 6.36 | 54.14 | 40.91 | |
19 | PharmacoEconomics | journal | 1.321 Q1 | 118 | 109 | 356 | 4978 | 1417 | 310 | 3.53 | 45.67 | 43.96 | |
20 | Emerging Contaminants | journal | 1.227 Q1 | 36 | 22 | 83 | 1405 | 448 | 82 | 5.29 | 63.86 | 36.45 | |
21 | Biomedicine and Pharmacotherapy | journal | 1.194 Q1 | 149 | 1366 | 4433 | 107284 | 32385 | 4421 | 7.33 | 78.54 | 44.57 | |
22 | Asian Journal of Pharmaceutical Sciences | journal | 1.175 Q1 | 66 | 64 | 184 | 4952 | 1599 | 181 | 9.00 | 77.38 | 42.42 | |
23 | Clinical and Translational Science | journal | 1.162 Q1 | 60 | 263 | 314 | 9245 | 1534 | 277 | 4.76 | 35.15 | 38.59 | |
24 | EPMA Journal | journal | 1.147 Q1 | 52 | 36 | 109 | 4149 | 862 | 108 | 8.81 | 115.25 | 40.61 | |
25 | Frontiers in Pharmacology | journal | 1.143 Q1 | 154 | 4009 | 5230 | 262406 | 33132 | 5134 | 5.69 | 65.45 | 45.75 | |
26 | Life Sciences | journal | 1.132 Q1 | 191 | 1232 | 2782 | 85781 | 17820 | 2776 | 6.55 | 69.63 | 45.84 | |
27 | Drugs in Context | journal | 1.130 Q1 | 36 | 63 | 166 | 3820 | 1008 | 166 | 5.04 | 60.63 | 50.92 | |
28 | Biomarker Insights | journal | 1.108 Q1 | 40 | 18 | 57 | 962 | 303 | 54 | 3.21 | 53.44 | 36.67 | |
29 | Drug Delivery | journal | 1.092 Q1 | 95 | 221 | 458 | 12251 | 3576 | 458 | 6.71 | 55.43 | 43.74 | |
30 | Human Vaccines and Immunotherapeutics | journal | 1.073 Q1 | 93 | 726 | 1278 | 28982 | 5265 | 1105 | 4.08 | 39.92 | 48.17 | |
31 | Altex | journal | 1.058 Q1 | 64 | 58 | 183 | 2608 | 827 | 159 | 3.98 | 44.97 | 52.00 | |
32 | International Journal of Nanomedicine | journal | 1.032 Q1 | 179 | 496 | 1968 | 35384 | 14741 | 1965 | 7.10 | 71.34 | 43.82 | |
33 | Journal of Food and Drug Analysis | journal | 1.018 Q1 | 79 | 52 | 293 | 2501 | 2046 | 291 | 6.40 | 48.10 | 43.58 | |
34 | Vaccines | journal | 1.004 Q1 | 85 | 1502 | 1076 | 91267 | 5345 | 1038 | 4.89 | 60.76 | 46.88 | |
35 | International Journal of Pharmaceutics | journal | 1.000 Q1 | 258 | 1064 | 2705 | 66681 | 18306 | 2696 | 6.48 | 62.67 | 43.47 | |
36 | Infection and Drug Resistance | journal | 0.944 Q1 | 65 | 542 | 1115 | 21858 | 5304 | 1098 | 4.33 | 40.33 | 42.36 | |
37 | F1000Research | journal | 0.939 Q1 | 105 | 650 | 2151 | 22035 | 8181 | 2109 | 3.58 | 33.90 | 39.95 | |
38 | OpenNano | journal | 0.932 Q1 | 21 | 2 | 12 | 106 | 151 | 12 | 10.00 | 53.00 | 50.00 | |
39 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 0.923 Q2 | 47 | 56 | 170 | 4075 | 737 | 168 | 4.35 | 72.77 | 39.25 | |
40 | Pharmaceutics | journal | 0.922 Q1 | 106 | 2186 | 2205 | 171605 | 15403 | 2175 | 6.44 | 78.50 | 46.77 | |
41 | Cancer Nanotechnology | journal | 0.921 Q1 | 36 | 33 | 37 | 2004 | 295 | 35 | 7.46 | 60.73 | 46.78 | |
42 | Journal of Cardiovascular Development and Disease | journal | 0.897 Q1 | 32 | 188 | 159 | 10975 | 621 | 153 | 4.21 | 58.38 | 37.60 | |
43 | Cancer Biology and Therapy | journal | 0.888 Q2 | 130 | 62 | 442 | 3198 | 1951 | 437 | 4.33 | 51.58 | 34.35 | |
44 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.884 Q1 | 86 | 82 | 1133 | 2645 | 7255 | 1132 | 5.62 | 32.26 | 38.11 | |
45 | Toxins | journal | 0.884 Q1 | 116 | 908 | 2084 | 63017 | 10731 | 2047 | 4.90 | 69.40 | 45.95 | |
46 | Advances in Pharmacological Sciences | journal | 0.862 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
47 | Pharmaceuticals | journal | 0.851 Q1 | 87 | 1335 | 802 | 103239 | 4450 | 793 | 5.01 | 77.33 | 47.76 | |
48 | Pharmacology Research and Perspectives | journal | 0.851 Q1 | 43 | 197 | 296 | 9826 | 876 | 291 | 2.91 | 49.88 | 42.95 | |
49 | Cancer Chemotherapy and Pharmacology | journal | 0.848 Q1 | 122 | 174 | 680 | 6355 | 2399 | 669 | 3.31 | 36.52 | 34.82 | |
50 | Antiviral Chemistry and Chemotherapy | journal | 0.844 Q1 | 59 | 9 | 38 | 232 | 178 | 36 | 3.00 | 25.78 | 41.18 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®